EMG
GRNA

ETF Managers Group’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

ETF Managers Group’s Portfolio GRNA Stock Details GRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$22.3K Buy
51,545
+13,761
+36% +$10.6K ﹤0.01% 673
2022
Q4 		$44.6K Buy
37,784
+1,284
+4% +$2.09K ﹤0.01% 499
2022
Q3 		$85K Buy
+36,500
New +$95.6K ﹤0.01% 655

Other funds holding GRNA

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
CGC
Continental Grain Company New York $448M AUM 6.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tao Capital Management San Francisco, California $1.94B AUM 48.68% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

ETF Managers Group's GRNA Position: Q1 2023 in Review

ETF Managers Group increased its GreenLight Biosciences Holdings, PBC Common Stock (GRNA) stake by 36% in Q1 2023, buying an estimated $10.6K and bringing the position to 51,545 shares worth $22.3K. The position accounts for ﹤0.01% of the portfolio, ranked #673.

ETF Managers Group first reported a position in GRNA in Q3 2022 and has held it in 3 quarters since. The position peaked at $85K in Q3 2022. 60 funds tracked by Wall St. Rank hold GRNA as of Q1 2023.

  • ETF Managers Group held 51,545 shares of GreenLight Biosciences Holdings, PBC Common Stock worth $22.3K as of Q1 2023.
  • ETF Managers Group bought 13,761 GreenLight Biosciences Holdings, PBC Common Stock shares in Q1 2023, an estimated $10.6K.
  • GreenLight Biosciences Holdings, PBC Common Stock made up ﹤0.01% of ETF Managers Group's portfolio in Q1 2023, its #673 holding.
  • ETF Managers Group first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q3 2022 and has held it in 3 quarters since.
  • ETF Managers Group's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $85K in Q3 2022.
  • 60 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.